Press Releases
St. Jude Medical Completes Acquisition of LightLab Imaging St. Jude Medical, Inc. (NYSE:STJ), a global medical device company,
today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90
million in cash.
Read the release >>
LightLab Imaging Returns to EuroPCR 2010 with Strong and Growing Worldwide Acceptance of C7-XR OCT Imaging System LightLab Imaging Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) technology for coronary and other imaging applications will showcase its C7-XR™ Imaging System and its companion C7 Dragonfly™ Imaging Catheter at EuroPCR 2010 in Paris, France.
Read the release >>
LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America LightLab Imaging Inc. announced today that Good Morning America featured Dr. Marco Costa, a leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University Hospitals, Case Western Reserve University, using the newest imaging technology available to hospitals in the United States – Optical Coherence Tomography.
Read the release >>
View the video... >>
St. Jude Medical to Acquire LightLab Imaging St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, and LightLab Imaging, Inc. today announced a definitive agreement under which St. Jude Medical will acquire LightLab
Read more >>
LightLab Imaging Announces FDA Clearance
of C7-XR™ Coronary OCT Products in the United States
LightLab Imaging Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) technology for vascular and other imaging applications, has received clearance from the U.S. Food and Drug Administration (FDA) for the C7-XR Imaging System and companion C7 Dragonfly Imaging Catheter.
Read more >>
LightLab Highlights OCT Market Leadership at the Society for Cardiovascular Angiography and Interventions
LightLab Imaging Inc., the pioneer in development and world leader in sales of Optical Coherence Tomography (OCT) systems for vascular and other imaging applications, will exhibit at the Society for Cardiovascular Angiography and Interventions (SCAI) meeting in San Diego, CA May 5 to 8, in booth 28.
Read more >>
Date Set for LightLab Damages Trial Against Volcano and Axsun
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Read more >>
LightLab Imaging Receives Prism Award: Life Sciences award presented for C7 XR Optical Coherence Tomography Imaging System
LightLab Imaging Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) for vascular and other imaging applications, today announced the receipt of the Prism Award for Photonics Innovation in the life sciences category.
Read more >>
Watch Prism Award video as
LightLab CTO Joe Schmitt describes C7-XR intravascular imaging system >>
GE Healthcare and LightLab Imaging Inc. Collaborate on Cardiovascular Imaging: Joint efforts focus on Optical Coherence Tomography (OCT)
GE Healthcare, a global leader in healthcare solutions and LightLab Imaging Inc., a market leader in optical imaging, today announced a collaboration that enables improved workflow between GE Healthcare’s Innova® cardiovascular X-ray system.
Read more >>
LightLab Imaging Introduces World’s Highest Resolution OCT System For Intracoronary Imaging At EUROPCR 2009: Launch of C7-XR™ FD-OCT™ Imaging System and Companion C7 Dragonfly™ Imaging Catheter Strengthen LightLab’s Market Leadership
LightLab Imaging Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) for vascular and other applications, today announced the launch of its next-generation system, the C7-XR FD-OCT Imaging System with the C7 Dragonfly Imaging Catheter, at EuroPCR 2009.
Read more >>
LightLab Imaging Leads Global Advancement Of Intracoronary Imaging: Finishes 2008 with More Than 300 Systems in 20 Countries and a 45% Increase in Per-System Catheter UtilizationTotal OCT Image Procedures Performed Surpass 10,000
LightLab Imaging Inc. today announced several important developments in the field this past year that are the culmination of sustained clinical and technology investment by the company. These advances significantly increase the Company’s leadership position in intravascular optical coherence tomography, or OCT.
Read more >>
LightLab Imaging Appoints Chief Financial Officer
LightLab Imaging, Inc., the global leader in Optical Coherence Tomography (OCT) Imaging for Cardiac and other applications, today announced the appointment of Mr. Warren (Renny) Clark III, as Chief Financial Officer.
Read more >>
David W. Kolstad Appointed President And Chief Executive Officer Of LightLab Imaging
LightLab Imaging, Inc., the world leader in photonic imaging technologies for medical applications, today announced the appointment of Mr. David W. Kolstad as Chief Executive Officer of the corporation.
Read more >>
LightLab Imaging Announces Live Broadcast Of First-In-Man Cases With Next Generation OCT Coronary Imaging System
LightLab Imaging, Inc. today announced performance of first-in-man cases with its next generation OCT Coronary Imaging System. The cases were broadcast live from Siegburg, Germany, to an audience of over 1,000 attendees in the Main Arena of the Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington D.C. on October 24, 2007.
Read more >>
LightLab Imaging Announces Successful Completion Of Pre-Clinical Study Of Next Generation OCT Imaging System
LightLab Imaging, Inc. today announced that it has successfully completed initial pre-clinical testing of its next generation Optical Coherence Tomography (OCT) System for coronary imaging. This next generation OCT Imaging System, has image acquisition speeds of approximately ten times faster than the Company's existing OCT product, and resolution three times greater.
Read more >>
